- Home
- VRAX vs GITS Comparison
VRAX vs GITS Comparison
Compare VRAX & GITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- GITS
- Stock Information
- Founded
- VRAX 2013
- GITS 2018
- Country
- VRAX United Kingdom
- GITS South Korea
- Employees
- VRAX N/A
- GITS N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GITS
- Sector
- VRAX Health Care
- GITS
- Exchange
- VRAX Nasdaq
- GITS Nasdaq
- Market Cap
- VRAX 4.7M
- GITS 5.1M
- IPO Year
- VRAX 2022
- GITS N/A
- Fundamental
- Price
- VRAX $0.79
- GITS $1.36
- Analyst Decision
- VRAX Strong Buy
- GITS
- Analyst Count
- VRAX 1
- GITS 0
- Target Price
- VRAX $3.00
- GITS N/A
- AVG Volume (30 Days)
- VRAX 38.7K
- GITS 102.0K
- Earning Date
- VRAX 02-05-2025
- GITS 07-15-2025
- Dividend Yield
- VRAX N/A
- GITS N/A
- EPS Growth
- VRAX N/A
- GITS N/A
- EPS
- VRAX N/A
- GITS N/A
- Revenue
- VRAX $84,872.00
- GITS N/A
- Revenue This Year
- VRAX $5,169.18
- GITS N/A
- Revenue Next Year
- VRAX $66.97
- GITS N/A
- P/E Ratio
- VRAX N/A
- GITS N/A
- Revenue Growth
- VRAX 7.03
- GITS N/A
- 52 Week Low
- VRAX $0.74
- GITS $0.87
- 52 Week High
- VRAX $9.00
- GITS $9.78
- Technical
- Relative Strength Index (RSI)
- VRAX 31.75
- GITS N/A
- Support Level
- VRAX $0.75
- GITS N/A
- Resistance Level
- VRAX $0.85
- GITS N/A
- Average True Range (ATR)
- VRAX 0.07
- GITS 0.00
- MACD
- VRAX -0.01
- GITS 0.00
- Stochastic Oscillator
- VRAX 6.57
- GITS 0.00
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.